Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 11 | 2022 | 68 | 3.410 |
Why?
|
| Cone-Beam Computed Tomography | 8 | 2018 | 41 | 2.660 |
Why?
|
| Phantoms, Imaging | 11 | 2021 | 101 | 2.020 |
Why?
|
| Algorithms | 10 | 2022 | 431 | 1.990 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2018 | 254 | 1.770 |
Why?
|
| Electrons | 2 | 2022 | 27 | 1.430 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2018 | 58 | 1.430 |
Why?
|
| Radiotherapy Dosage | 10 | 2021 | 107 | 1.150 |
Why?
|
| Radiotherapy, Intensity-Modulated | 4 | 2018 | 39 | 1.040 |
Why?
|
| Radiosurgery | 5 | 2016 | 84 | 1.030 |
Why?
|
| Radiometry | 6 | 2022 | 45 | 1.020 |
Why?
|
| Models, Theoretical | 3 | 2018 | 134 | 0.930 |
Why?
|
| Models, Statistical | 4 | 2016 | 128 | 0.920 |
Why?
|
| Artifacts | 4 | 2014 | 51 | 0.890 |
Why?
|
| Respiratory Mechanics | 2 | 2015 | 17 | 0.870 |
Why?
|
| Brain Neoplasms | 4 | 2016 | 313 | 0.820 |
Why?
|
| Patient Positioning | 3 | 2016 | 23 | 0.700 |
Why?
|
| X-Ray Film | 3 | 2012 | 10 | 0.680 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2014 | 481 | 0.670 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2016 | 130 | 0.650 |
Why?
|
| Radiotherapy Setup Errors | 2 | 2016 | 5 | 0.610 |
Why?
|
| Monte Carlo Method | 4 | 2021 | 62 | 0.600 |
Why?
|
| Thorax | 1 | 2018 | 29 | 0.550 |
Why?
|
| Film Dosimetry | 3 | 2012 | 8 | 0.480 |
Why?
|
| Quality Assurance, Health Care | 3 | 2013 | 64 | 0.440 |
Why?
|
| Radiographic Image Enhancement | 1 | 2014 | 28 | 0.420 |
Why?
|
| Models, Biological | 1 | 2016 | 469 | 0.410 |
Why?
|
| Immobilization | 2 | 2010 | 15 | 0.400 |
Why?
|
| Neoplasms | 2 | 2013 | 874 | 0.380 |
Why?
|
| Humans | 20 | 2022 | 28912 | 0.380 |
Why?
|
| Brachytherapy | 2 | 2009 | 54 | 0.360 |
Why?
|
| Radiography | 2 | 2010 | 203 | 0.360 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2011 | 4 | 0.340 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 360 | 0.330 |
Why?
|
| Head | 1 | 2010 | 19 | 0.320 |
Why?
|
| Motion | 4 | 2014 | 27 | 0.320 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 302 | 0.320 |
Why?
|
| Radiotherapy | 1 | 2010 | 41 | 0.310 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 70 | 0.310 |
Why?
|
| Densitometry | 1 | 2009 | 9 | 0.300 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 107 | 0.290 |
Why?
|
| Ultrasonography | 1 | 2009 | 243 | 0.280 |
Why?
|
| Sensitivity and Specificity | 5 | 2014 | 524 | 0.260 |
Why?
|
| Movement | 3 | 2018 | 100 | 0.260 |
Why?
|
| Parkinsonian Disorders | 1 | 2006 | 2 | 0.250 |
Why?
|
| Quinolones | 1 | 2006 | 22 | 0.250 |
Why?
|
| Psychotic Disorders | 1 | 2006 | 23 | 0.250 |
Why?
|
| Antipsychotic Agents | 1 | 2006 | 24 | 0.250 |
Why?
|
| Piperazines | 1 | 2006 | 50 | 0.240 |
Why?
|
| Parkinson Disease | 1 | 2006 | 47 | 0.240 |
Why?
|
| Photons | 2 | 2022 | 27 | 0.200 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2003 | 4 | 0.200 |
Why?
|
| Depressive Disorder | 1 | 2003 | 56 | 0.190 |
Why?
|
| Reproducibility of Results | 4 | 2014 | 787 | 0.180 |
Why?
|
| Radiotherapy, Conformal | 2 | 2012 | 15 | 0.170 |
Why?
|
| Prostheses and Implants | 2 | 2009 | 28 | 0.150 |
Why?
|
| Radiation Dosage | 2 | 2015 | 54 | 0.130 |
Why?
|
| Uncertainty | 1 | 2016 | 25 | 0.120 |
Why?
|
| Hippocampus | 1 | 2015 | 198 | 0.100 |
Why?
|
| Lung | 1 | 2016 | 384 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2014 | 238 | 0.100 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2012 | 16 | 0.090 |
Why?
|
| Kinetics | 2 | 2009 | 553 | 0.080 |
Why?
|
| Quality Control | 1 | 2010 | 21 | 0.080 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2010 | 4 | 0.080 |
Why?
|
| Radiation Monitoring | 1 | 2010 | 8 | 0.080 |
Why?
|
| Surface Properties | 1 | 2010 | 134 | 0.080 |
Why?
|
| Prosthesis Implantation | 1 | 2009 | 26 | 0.080 |
Why?
|
| Skin | 1 | 2010 | 153 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2010 | 93 | 0.070 |
Why?
|
| Spinal Neoplasms | 1 | 2008 | 40 | 0.070 |
Why?
|
| Temperature | 1 | 2009 | 213 | 0.070 |
Why?
|
| Prognosis | 1 | 2009 | 811 | 0.060 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2006 | 2 | 0.060 |
Why?
|
| Aripiprazole | 1 | 2006 | 2 | 0.060 |
Why?
|
| Neurologic Examination | 1 | 2006 | 22 | 0.060 |
Why?
|
| Equipment Failure Analysis | 1 | 2004 | 38 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2004 | 69 | 0.050 |
Why?
|
| Middle Aged | 3 | 2015 | 7420 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2009 | 2426 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2003 | 146 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 245 | 0.040 |
Why?
|
| Male | 3 | 2015 | 13947 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 2065 | 0.040 |
Why?
|
| Female | 2 | 2015 | 15651 | 0.030 |
Why?
|
| Aged | 2 | 2015 | 5604 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2016 | 2638 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 32 | 0.020 |
Why?
|
| Gold | 1 | 2008 | 137 | 0.020 |
Why?
|
| Cesium Radioisotopes | 1 | 2006 | 4 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2006 | 37 | 0.020 |
Why?
|
| Calibration | 1 | 2006 | 29 | 0.020 |
Why?
|
| X-Rays | 1 | 2006 | 31 | 0.020 |
Why?
|
| Adult | 1 | 2015 | 8038 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 1615 | 0.010 |
Why?
|